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Background: Respiratory syncytial virus (RSV) is the leading cause of respiratory infections in children, elderly, and
immunocompromised individuals. Severe infection is associated with short- and long-term morbidity including
pneumonia, recurrent wheezing, and abnormal pulmonary function, and several lines of evidence indicate that
impaired adaptive immune responses during infection are critical in the pathophysiology of RSV-mediated disease.
Myeloid Dendritic cells (mDCs) play a pivotal role in shaping antiviral immune responses in the respiratory tract;
however, few studies have examined the interactions between RSV and individual mDC subsets. In this study, we
examined the effect of RSV on the functional response of primary mDC subsets (BDCA-1+ and BDCA-3+) isolated
from peripheral blood.
Methods: BDCA-1+ and BDCA-3+ mDCs were isolated from the peripheral blood of healthy adults using FACS
sorting. Donor-matched BDCA-1+ and BDCA-3+ mDCs were infected with RSV at a multiplicity of infection (MOI) of
5 for 40 hours. After infection, cells were analyzed for the expression of costimulatory molecules (CD86, CD80, and
PD-L1), cytokine production, and the ability to stimulate allogenic CD4+ T cell proliferation.
Results: Both BDCA-1+ and BDCA-3+ mDCs were susceptible to infection with RSV and demonstrated enhanced
expression of CD86, and the inhibitory costimulatory molecules CD80 and PD-L1. Compared to BDCA-3+ mDCs,
RSV-infected BDCA-1+ mDC produced a profile of cytokines and chemokines predominantly associated with
pro-inflammatory responses (IL-1β, IL-6, IL-12, MIP-1α, and TNF-α), and both BDCA-1+ and BDCA-3+ mDCs were
found to produce IL-10. Compared to uninfected mDCs, RSV-infected BDCA-1+ and BDCA-3+ mDCs demonstrated a
reduced capacity to stimulate T cell proliferation.
Conclusions: RSV infection induces a distinct pattern of costimulatory molecule expression and cytokine
production by BDCA-1+ and BDCA-3+ mDCs, and impairs their ability to stimulate T cell proliferation.
The differential expression of CD86 and pro-inflammatory cytokines by highly purified mDC subsets in response to
RSV provides further evidence that BDCA-1+ and BDCA-3+ mDCs have distinct roles in coordinating the host
immune response during RSV infection. Findings of differential expression of PD-L1 and IL-10 by infected mDCs,
suggests possible mechanisms by which RSV is able to impair adaptive immune responses.
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Respiratory Syncytial Virus (RSV), a ssRNA pneumovi-
rus of the paramyxoviridae family, is the leading cause
of acute lower respiratory tract infections in children,
elderly, and immunocompromised patients. More than
95% of children become infected with RSV by 2 years of
age, and approximately 50% of children infected in the
first year of life are reinfected during the second year
[1]. Reinfection continues throughout life, re-emerging
as a major cause of community-acquired pneumonia in
the elderly [2]. RSV infection is associated with short-
and long-term morbidity including pneumonia, recu-
rrent wheezing, and abnormal pulmonary function.
Moreover, RSV bronchiolitis has been identified as the
highest independent risk factor for the development of
asthma and allergic sensitization later in life [3].
Primary RSV infection is controlled by T cell responses
which are crucial in viral clearance and limiting disease
severity. Weak antiviral cytotoxic responses and decreased
numbers of CD4+ and CD8+ T cells in the lower respira-
tory tract of infants with severe infection [4,5] along with
the susceptibility to repeat infections with RSV strongly
suggest that the failure to develop adaptive T cell re-
sponses is critical in the pathophysiology of RSV-mediated
disease. Additionally, the balance between Th1 and Th2
cytokines produced by T cells plays a crucial role in deter-
mining the outcome of infection, and severe RSV infection
may be associated with skewing the Th1/Th2 balance of
the virus-specific response towards Th2 [6,7]. However,
the mechanisms by which RSV is able to manipulate host
immunity are not fully understood.
Dendritic cells (DCs) are an important first line of
defense against invading pathogens and are regarded as
the most potent antigen presenting cell (APC) type.
Upon antigen recognition, DCs produce cytokines and
costimulatory signals needed to guide T cell differenti-
ation, ultimately determining the quality and quantity of
the resulting immune response. Human DC populations
are defined based on their lineage and expression of
unique Blood Dendritic Cell Antigens (BDCA), and de-
pending on their derivation, direct immune responses
through either the initiation or modulation of immunity.
Plasmacytoid DCs (pDCs), characterized by expression
of BDCA-2, mediate antiviral immunity via the produc-
tion of IFN-α [8]. Myeloid DCs (mDCs) are particularly
efficient in the uptake, processing and presentation of
antigens and can be further subdivided into distinct sub-
sets identified by differential expression of either BDCA-
1 (BDCA-1+) or BDCA-3 (BDCA-3+).
The lung contains an elaborate network of dendritic
cells that regulate the local environment. During respira-
tory infections, both tissue-resident DCs, as well as
recruited DCs, are activated as part of the host immune
response [9]. Although present at much lower frequenciesthan BDCA-1+ mDCs in peripheral blood, the DC net-
work in the airway mucosa is comprised predominately of
BDCA-3+ mDCs [10]. Studies of mDC subsets isolated
from human lungs and blood suggest that each subset ex-
hibits distinct roles in coordinating the immune response
against pathogens [11-14]. Although the relationship be-
tween mDCs found in the lung and peripheral blood is
not clear, parallel phenotypic analysis and transcriptome
mapping provides evidence that lung and other non-
lymphoid tissue BDCA-3+ mDCs are potentially related to
blood BDCA-3+ mDCs [15]. The relationship of blood to
tissue BDCA-1+ mDCs was not as clearly defined, but did
show clustering of their gene signatures [15]. Thus, even
though it is likely that lung DCs may in some ways be
functionally distinct from blood DCs, these studies dem-
onstrate that blood mDC subsets are potentially related to
mDC subsets found in tissues.
As key regulators of immunity, DCs are an ideal target
for the virus to exert its immune altering mechanisms.
In this regard, a possible role for mDCs in RSV infection
is evidenced by observations of increased numbers of
mDCs in the airways, and decreased numbers of mDCs
in the blood of children with acute RSV infection,
suggesting that DCs are recruited out of the blood to
the site of infection [16]. Correlations between the
number of mDCs and the level of pro-inflammatory
cytokines in the nasal cavity of RSV-infected patients in-
dicates that mDCs may represent an important source
of inflammatory cytokines during the host immune
response against infection [16]. Additionally, RSV infec-
tion inhibits the capacity of monocyte derived DCs
(Mo-DCs) to stimulate T-cell proliferation in vitro
[17,18] and impairs the function of pulmonary DCs in
RSV-infected mice [19]. Taken together, these results
suggest that infection with RSV impairs the ability of
host immune response to adequately clear viral patho-
gens by altering DC mediated immune responses.
However, current RSV-mDC studies often utilize
murine DCs or mDCs derived in vitro from human
monocytes, and even though Mo-DCs have many char-
acteristics similar to myeloid blood DCs [20-22], studies
have not shown direct functional correlations between
in vitro derived Mo-DCs and individual mDC subsets
isolated from lymph nodes or blood [14,23,24]. Thus,
studies using Mo-DCs may not adequately recapitulate
the function of primary mDCs during RSV infection.
Few studies have examined the interactions between
viral pathogens and primary human mDC subsets, espe-
cially BDCA-3+ mDCs. To identify cell-specific re-
sponses of primary mDC subsets to RSV infection, we
examined the expression of costimulatory markers and
production of cytokines by BDCA-1+ and BDCA-3+
mDCs after exposure to RSV. The functional response
after infection was evaluated by examining their ability
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reaction. To our knowledge, this is one of the first stud-
ies to examine the functional response of highly purified
BDCA-1+ and BDCA-3+ mDCs to RSV.
Materials and methods
Isolation of mDC subsets
Buffy coats prepared by the University of Texas Medical
Branch (UTMB) blood blank from healthy adult donors
who fulfilled criteria for blood donations were obtained.
The donor’s identity, race, and age remained anonymous
to investigators. This study was approved by UTMB’s In-
stitutional Review Board. Peripheral blood mononuclear
cells (PBMCs) were separated from buffy coats by Ficoll-
hypaque density centrifugation and enriched for mDCs
using an mDC cell isolation kit (Miletnyi Biotec,
Auburn, CA) to deplete magnetically labeled non-mDCs.
In preparation for FACS sorting, the DC enriched
fraction was stained with the following fluorochrome-
conjugated monoclonal antibodies (mAbs[clone]): PE-
BDCA-3[1A4], APC-BDCA-1[AD5-8E7], FITC-BDCA-2
[AC144], and FITC-lineage marker cocktail containing
CD3[SK7], CD14[MΦP9], CD16[3G8], CD19[SJ25C1],
CD20[L27], CD56[NCAM16.2] purchased from eBio-
sciences (San Diego, CA), Miltenyi Biotec, and BD Bio-
sciences (San Jose, CA) respectively. Cells were stained
in the presence of FcR-blocking reagent (Miltenyi
Biotec) to minimize non-specific binding.
Sorting and flow cytometric data acquisition was
performed on a FACSAria (BD Biosciences) capable of
9-color analysis running FACS Diva software. BDCA-3+
mDCs were sorted as FITC-, APC-, PEhi and BDCA-1+
were sorted as FITC-, APC+, PEdim with routine post-
sort analysis to ensure purity ≥95%.
Virus preparation and infection
Preparation of sucrose-purified RSV (Long strain) has
been previously described [18]. RSV was inactivated by
exposing the virus to ultraviolet light [18]. For infection,
1×104 cells of donor-matched BDCA-1+ or BDCA-3+
mDCs were resuspended in 200 μl of cRPMI (RPMI
1640 medium + 2 mmol/liter L-glutamine + 10% FBS +
50 μM 2-ME + 100UI/ml penicillin-streptomycin) and
incubated for 40 hours at 37°C with RSV or ultraviolet-
inactivated RSV (UV-RSV) at a multiplicity of infection
(MOI) of 5 [18,25]. As TLR3 is known to be expressed
on BDCA-1+ and BDCA-3+ mDCs [13], cells cultured in
the presence of 10 μg/ml of purified poly I:C (InvivoGen,
San Diego, CA) served as positive controls and unin-
fected cells served as negative controls.
FACS analysis of DCs
Mock and RSV-infected BDCA-1+ and BDCA-3+ mDCs
were first stained with Fixable Viability Dye eFlour 780(eBioscience). To detect intracellular expression of
RSV antigens, BDCA-1+ and BDCA-3+ mDCs were
fixed with Cytofix/Cytoperm™ (Pharmingen), perme-
abilized with Perm/Wash™ buffer (Pharmingen),
and stained with FITC-conjugated anti-RSV antibody
(Biosource, Camarillo, CA) as previously described
[18]. For costimulatory molecule analysis, mDCs were
stained with FITC-PD-L1[M1H1], v450-CD86[2331
(FUN-1)], and PE-Cy7-CD80[L307.4] (BD Biosciences)
or in a separate set of experiments, PerCP Cy5.5-
HLA-DR[L243]. Flow cytometric data acquisition was
performed on a BD LSRII Fortessa capable of 18-
color analysis running FACS Diva software (BD Bio-
sciences). FloJo V7.6.3 software was used to analyze
all flow cytometry data.
Bio-plex assay
After 40 hours, cell free supernatants were collected and
tested for cytokines IL-1β, IL-1rα IL-6, IL-7, IL-8, IL-10,
IL-12(p70), IFN-γ, CXCL10, TNF-α, G-CSF, MCP-1,
MIP-1α, MIP-1β, and RANTES using the Luminex-
based Bio-Plex system (Bio-Rad Laboratories, Hercules,
CA). The lower limit of detection for all cytokines mea-
sured in this assay is 3 pg/ml. When comparing cytokine
production between subsets, the fold change in concen-
tration (infected/uninfected) was used to normalize re-
sults across cell types.
Allogenic MLR
Allogenic CD4+ T cells were isolated from PBMCs by
negative immunomagnetic selection using a CD4+ T
cell isolation kit (Miletnyi Biotec, Auburn, CA). Rou-
tine post sort purity was >96% as determined by flow
cytometry. To track proliferation, T cells were labeled
with 10 μM CFSE (Invitrogen, Grand Island, NY)
according to the manufacturer’s instructions. Donor
matched BDCA-1+ and BDCA-3+ mDCs were incu-
bated for 24 hours at 37°C with RSV, UV- RSV, or
poly I:C. After 24 hours, cells were washed and
cocultured with the CFSE-labeled allogenic T cells at
a ratio of 1:5 in RPMI containing 5% FCS for 6 days
at 37°C. T cells alone and T cells incubated with sol-
uble CD3 and CD28 were included as controls. Prior
to flow cytometry, cells were stained with PerCP-Cy™
5.5-CD3[SK7] and PE-Cy™ 7-CD4[RPT-A] (BD Biosci-
ences). Proliferation of CD3+ CD4+ T cells was mea-
sured on a BD LSRII Fortessa running FACS Diva
software (BD Biosciences) and analyzed using FloJo
V7.6.3 software.
Statistical analysis
Statistical Analysis was performed with InStat 5.02 bio-
statistics package (GraphPad Software, San Diego, CA)
using student’s paired t-tests to ascertain differences
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or student’s t-tests to ascertain differences between cell
types. Significance was defined as p ≤0.05. Prior to ana-
lysis, data sets were log transformed to normalize non-
normally distributed data.
Results
Isolation and characterization of mDC subsets
MDC subsets were isolated from PBMCs using a two
step procedure [13]. PBMCS were first enriched for
mDCs using a myeloid dendritic cell isolation kit toFigure 1 Isolation and phenotypic characterization of mDC subsets. (
debris. Cells were then gated to exclude lineage positive cells and pDCs. L
and BDCA-3. BDCA-1+ mDCs were sorted as Lin-, BDCA-2-, BDCA-1+, BDCA-
3hi. (B) Post-sort purity for all sorted cells was ≥95%. Data is from one don
costimulatory molecules by freshly isolated cells. Filled curves= isotype, soldeplete non-myeloid DCs via negative immunoselec-
tion, followed by flow cytometry to eliminate residual
pDCs and lineage positive cells and sort for BDCA-1+
and BDCA-3+ cells (Figure 1A). Consistent with
reported frequencies in blood [13], we were routinely
able to isolate approximately 1×104 BDCA-3+ mDCs
per 1×108 PBMCS and 1×105 BDCA-1+ mDCs
per 1×108 PBMCs with a post-sort purity ≥95%
(Figure 1B). At baseline, both subsets demonstrated
similar expression of HLA-DR and CD86, but did not
express CD80 or PD-L1 (Figure 1C).A) PBMCs were gated on SSC and FSC to exclude dead cells and
ineage (Lin)-, BDCA-2- cells were then gated for expression of BDCA-1
3dim and BDCA-3+ mDCs were sorted as Lin-, BDCA-2-, BDCA-1-, BDCA-
or and is representative of 6 donors. (C) Expression of maturation and
id line=mDC. Data is from one donor and is representative of 3 donors.
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Work from our lab has previously shown that human
Mo-DCs are permissive to RSV infection [18]. To deter-
mine the susceptibility of primary mDCs to infection,
the intracellular expression of viral proteins by BDCA-1+
and BDCA-3+ infected with RSV at a MOI=5 for 12, 24,
or 40 hours was examined using flow cytometry. The
greatest percentage of infected cells was detected at 40
hours, with 20-25% of BDCA-1+ mDCs and 18-23% of
BDCA-3+ mDCs demonstrating expression of viral pro-
teins (Figure 2). Cells exposed to UV-RSV (non-replicating
virus) did not express RSV antigen. Cell viability decreased
between 24 and 40 hours; however, there was no differ-
ence in the number of viable cells after exposure to RSV
and UV-RSV at each time point. In BDCA1+ mDCs, max-
imal infection occurred at a MOI=5 and increasing the
MOI did not result in a further increase in the number of
virus-positive cells, whereas, in BDCA-3+ mDCs using an
MOI=10 did increase the number of virus-positive cells
by approximately 4% (data not shown). As there was no
statistically significant difference between the rates of in-
fection in BDCA-1+ and BDCA-3+ mDCs at a MOI=5,
this MOI was used for all subsequent RSV infection
experiments.
RSV infection modulates costimulatory molecule
expression
T cell activation depends, in addition to the binding of
MHC/peptide complexes by T cell receptors, on the rec-
ognition of positive or negative costimulatory molecules
expressed by DCs. Depending on whether they bind to
CD28 or CTLA-4 receptors on T cells, CD86 and CD80
expressed on mDCs can deliver either stimulatory
(CD28) or inhibitory (CTLA-4) signals for T cellFigure 2 BDCA-1+ and BDCA-3+ mDCs are susceptible to infection wi
alone or exposed to RSV and UV-inactivated RSV at a MOI=5 for 12, 24, or
and the percentage of RSV-infected cells was quantified using flow cytome
curve=uninfected cells, solid line=infected cells. Data is from one donor, anactivation. Additionally, the programmed death-1 (PD-1)
receptor and its ligands PD-L1 and PD-L2 deliver inhibi-
tory signals that regulate the balance between tolerance
vs. T cell activation and immune-mediated tissue dam-
age. Engagement of PD-1 by its ligands blocks T cell
proliferation and cytokine production [26] and promotes
the development, expansion, and survival of Tregs
[27,28]. Previous work from our lab demonstrated in-
creased expression of CD86, CD80, and PD-L1, but not
PD-L2, on RSV-infected Mo-DCs [18,19]. Therefore, to
assess the effect of RSV infection on the regulation of
costimulatory molecule expression in primary mDC sub-
sets, the expression of CD86, CD80, and PD-L1 was ex-
amined on RSV infected BDCA-1+ and BDCA-3+ mDCs
using flow cytometry. In all donors, both RSV-infected
BDCA-1+ and BDCA-3+ mDCs demonstrated enhanced
expression of CD86, CD80, and PD-L1 as compared to
uninfected cells (Figure 3A). However, CD86 expression
by RSV-infected BDCA-1+ mDCs was not found to be
significantly different from expression by uninfected cells
(Figure 3B). Exposure to UV-RSV also induced expres-
sion of CD86 and CD80 in BDCA-1+ and BDCA-3+
mDCs, but did not induce expression of PD-L1 in either
subtype (Additional file 1: Figure S1).
DC subsets express discreet TLR profiles [13,29], how-
ever both BDCA-1+ and BDCA-3+ mDCs have been
shown to express TLR3 [13]. Activation with poly I:C
upregulates the expression of costimulatory molecules
on BDCA-1+ and BDCA-3+ mDCs (Additional file 2:
Figure S2A-B). To characterize the strength and specifi-
city of costimulatory molecule expression induced by
RSV, the fold change in CD86, CD80, and PD-L1 expres-
sion by mDCs infected with RSV was compared to
mDCs activated with poly I:C. In BDCA-1+ mDCs, PD-th RSV. BDCA-1+ and BDCA-3+ mDCs were incubated in media
40 hours. Cells were stained for intracellular expression of RSV protein,
try to detect expression of anti-RSV antibody. Filled grey
d is representative of 3 donors.
Figure 3 RSV infection induces upregulation of costimulatory molecules on BDCA-1+ and BDCA-3+ mDCs. BDCA-1+ and BDCA-3+ mDCs
were incubated in media alone or infected with RSV at a MOI=5 for 40 h. (A) Costimulatory molecule expression was analyzed using flow
cytometry. Dashed line= uninfected cells, solid line = infected cells. Data is from one donor and is representative of 5 donors. (B) Bar graph
represent the change in mean fluorescent intensity (MFI) of expression by infected cells over uninfected cells (mean + SEM of 5 donors). Linear
data is reported on a logarithmic scale. The dotted line represents a 2 fold induction. *=statistically significant difference (p≤0.05) in expression by
infected mDCs as compared to uninfected mDCs by student’s paired t-test.
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cells than poly I:C activated cells (Figure 4A); in BDCA-
3+ mDCs, expression of CD86 and PD-L1 was signifi-
cantly greater on RSV-infected cells than poly I:C acti-
vated cells (Figure 4B). Together, these results suggest
although viral replication is not necessary for mDC acti-
vation; PD-L1 is differentially induced by RSV infection.
RSV infection induces cytokine production by BDCA-1+
and BDCA-3+ mDCs
The cytokines and chemokines produced by activated
mDCs affect both innate and adaptive immune re-
sponses. To examine the profile of cytokines produced
by primary mDC subsets in response to RSV, cytokine
production by RSV-infected BDCA-1+ and BDCA-3+
mDCs was examined using a Luminex-based assay.Compared to uninfected cells of the same type, RSV-
infected BDCA-1+ mDCs demonstrated significant
increases in the production of IL-1β, IL-1rα, IL-6, IL-8,
IL-10, IL-12, G-CSF, TNF-α, CXCL10, MCP-1, MIP-1α,
MIP-1β, and RANTES (Figure 5A). In three of the six
donors, IFN-γ was also produced by RSV-infected
BDCA-1+ mDCs, with high levels produced by only one
of the three (data not shown). The significance of these
findings is unclear since with the exception of IFN-γ, the
pattern of production for all other cytokines was consist-
ent among most donors. In RSV-infected BDCA-3+
mDCs, IL-8, IL-10, IL-12, and RANTES levels were
found to be significantly increased as compared to unin-
fected cells of the same type (Figure 5B), however for
most donors, the amount of IL-12 produced by RSV-
infected BDCA-3+ mDCs did not reach a 2 fold increase
Figure 4 Comparison of costimulatory molecule expressed by mDC subsets in response to RSV and poly I:C. (A) BDCA-1+ and (B) BDCA-
3+ mDCs were incubated in media alone, infected with RSV at a MOI=5, or activated with poly I:C for 40 h. Bar graphs represent the change in
mean fluorescent intensity (MFI) of expression by infected cells over uninfected cells (mean + SEM of 5 donors). Linear data is reported on a
logarithmic scale. The dotted line represents a 2 fold induction. *=statistically significant difference (p≤0.05) in expression by RSV-infected mDCs
as compared to poly I:C-activated mDCs by student’s paired t-test.
Figure 5 RSV infection induces cytokine production by BDCA-1+ and BDCA-3+ mDCs. (A) BDCA-1+ and (B) BDCA-3+ mDCs were isolated
and incubated with RSV or media for 40 hours. Cytokine and chemokine levels were measured in cell-free supernatant by multiplex assay. Data
represent cytokine production in pg/ml. Box and whisker plots show the median (central bar), interquartiles (boxes), and range (whiskers) of the
data from 6 donors. Linear data is reported on a logarithmic scale. *= Statistically significant (p≤0.05) difference in cytokine concentration
between infected and uninfected cells as calculated by student’s paired t-test.
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infected BDCA-3+ mDCs in any of the six donors. Over-
all, RSV induced a more robust cytokine response from
BDCA-1+ mDCs compared to BDCA-3+ mDCs. With
the exception of IL-12 and IP-10, exposure to both RSV
and UV-RSV induced cytokine production in BDCA-1+
and BDCA-3+ mDCs (data not shown) suggesting that
as in Mo-DCs, [30,31] viral replication is not necessary
for mDC activation. IFN-α is a key mediator of anti-viral
immunity. In a preliminary set of experiments with three
donors, production of IFN-α by RSV-infected BDCA-1+
and BDCA-3+ mDCs was measured using ELISA. Neither
BDCA-1+ or BDCA-3+ mDCs from any of the three do-
nors produced detectable levels of IFN-α (data not shown).
As these results coincided with previous findings in RSV-
infected Mo-DCs [18], no further donors were tested.Figure 6 Comparison of cytokines produced by mDC subsets in respo
isolated and incubated with RSV, poly I:C or media alone for 40 hours. Cyto
multiplex assay. Data represents the mean + SEM of the fold change in cyt
the same type from 5 donors. Linear data is reported on a logarithmic scal
significant (p≤0.05) difference in cytokine production by RSV-infected mDCBDCA-1+ and BDCA-3+ mDCs produce proinflamma-
tory cytokines in response to activation with poly I:C
(Additional file 3: Figures S3A and 3B). To characterize
the strength and specificity of the cytokines produced by
RSV-infected BDCA-1+ and BDCA-3+ mDCs, the fold
change (agonist/untreated) in cytokine production in
response to RSV and poly I:C was compared for each
subset. Although the cytokine profiles produced by
BDCA-1+ mDCs in response to RSV and poly I:C were
similar, RSV-infected BDCA-1+ mDCs did produce sig-
nificantly greater amounts of IL-1rα, IL-6, IL-8, IL-10,
MCP-1, MIP-1β, and TNF-α (Figure 6A). As compared
to activation with poly I:C, BDCA-3+ mDCs infected
with RSV produced significantly greater amounts of IL-
1rα and IL-10, but decreased amounts of IL-1β, IL-8,
MIP-1α, MIP-1β, and TNF-α (Figure 6B).nse to RSV and poly I:C. (A) BDCA-1+ and (B) BDCA-3+ mDCs were
kine and chemokine levels were measured in cell-free supernatant by
okine production by treated cells as compared to untreated cells of
e. The dotted line represents a 2 fold induction. *= Statistically
s as compared to poly I:C-activated mDCs by student’s paired t-test.
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The cytokine signature associated with Th2 skewing
is not as clearly defined; however along with IL-4,
IL-10 and low levels of IL-12 have been identified as
Th2 polarizing signals [32,33]. Other pro-inflamma-
tory cytokines and chemokines also regulate T cell
differentiation, and IL-1β, IL-6, TNF-α, MIP-1α, and
MIP-1β are reported to have important roles in pro-
moting DC maturation and inducing Th1 responses
[34-36]. To determine whether the cytokines and
chemokines associated with polarization of T cell
responses were differentially induced by RSV-infected
BDCA-3+ and BDCA-1+ mDCs, the fold change
(infected/uninfected) in production of these cytokines
by each cell type was compared (Figure 7). In general
the fold changes in cytokine and chemokine produc-
tion were lower in BDCA-3+ mDCs compared to
BDCA-1+ mDCs, which may in part be related to the
slightly higher levels of cytokine production by unin-
fected BDCA-3+ mDCs. Compared to BDCA-3+
mDCs, RSV-infected BDCA-1+ mDC were found to
produce significantly increased amounts of IL-1β, IL-
6, IL-12, MIP-1α, and TNF-α; production of MIP-1β
and IL-10 was not significantly different between the
two subsets. Neither BDCA-1+ or BDCA-3+ mDCs
were found to produce IL-4.
RSV infection impairs the capacity of BDCA-1+ and BDCA-
3+ mDCs to stimulate T cell proliferation
BDCA-1+ and BDCA-3+ mDCs are powerful and
equivalent stimulators of allogenic CD4+ T cells [13];
however, RSV-infected Mo-DCs demonstrate a de-
creased capacity to stimulate T-cell proliferation [17,18].
To assess whether RSV infection affects the capacity of
BDCA-1+ and BDCA-3+ mDCs to stimulate T cellFigure 7 Comparison of cytokines produced by RSV-infected BDCA-1
RSV or media for 40 hours. Cytokine and chemokine levels were measured in
SEM of the fold change in cytokine production by infected cells as compared
reported on a logarithmic scale. The dotted line represents a 2 fold induction
between RSV-infected BDCA-1+ and BDCA-3+ mDC as calculated by studentsproliferation, allogenic CD4+ T cells labeled with CFSE
were cocultured with BDCA-1 and BDCA-3 mDCs ex-
posed to RSV, or poly I:C for 6 days. T cell proliferation
was measured using flow cytometry to examine CFSE
expression by CD3+, CD4+ T cells. As compared to un-
infected DCs or those activated with poly I:C, RSV-
infected mDCs demonstrate a reduced capacity to
stimulate the proliferation of allogenic T cells; UV inacti-
vation of the virus restored the ability of BDCA-1+ and
BDCA-3+ mDCs to stimulate T cell proliferation
(Figure 8A-B).
Discussion
In this study, we examined the effect of RSV infection
on primary human mDC subsets isolated from periph-
eral blood. To ensure purity of the specific mDC popula-
tions among donors, BDCA-1+ and BDCA-3+ mDCs
were isolated using multicolor FACs sorting with param-
eters similar to those previously published [13]. This
method allowed us to consistently obtain sufficient num-
bers of both populations with purity ≥95% for all donors.
Similar to Mo-DCs [17,18], we demonstrate that primary
mDC subsets are susceptible to infection with RSV.
Consistent with previous reports [25], BDCA-1+ and
BDCA-3+ mDCs show similar rates of RSV infection.
While mDC activation is not dependent on viral replica-
tion, we demonstrate that RSV infection induces a dis-
tinct pattern of costimulatory molecule expression and
cytokine production by BDCA-1+ and BDCA-3+ mDCs,
and impairs their ability to stimulate T cell proliferation.
Enhanced expression of CD86, CD80, and PD-L1 on
RSV-infected mDCs coincides with the costimulatory
molecule expression on RSV-infected Mo-DCs and mur-
ine lung mDCs which have an impaired capacity to stimu-
late T cell proliferation [18,19]. These findings suggest that+ and BDCA-3+ mDCs. DC subsets were isolated and incubated with
cell-free supernatant by multiplex assay. Data represents the mean +
to uninfected cells of the same type from 6 donors. Linear data is
. *= Statistically significant (p≤0.05) difference in cytokine production
t-test.
Figure 8 RSV-infected BDCA-1+ and BDCA-3+ mDCs impair CD4+ T cell proliferation. BDCA-1+ and BDCA-3+ mDC were incubated with RSV,
UV-RSV, poly I:C or media for 24 hours. Cells were washed and cocultured with CFSE-labeled allogenic CD4+ T cells for 6 days, (A) On day 6, cells
were stained with mAb against CD3 and CD4, and T cell proliferation was measured by examining CFSE expression on CD3+, CD4+ T cells. Data is
from one donor and is representative of data from 3 donors. Bar graphs represent the percent of proliferating CD4+ CD3+ T cells after 6 days in
coculture with untreated or treated (B) BDCA-1+ and (C) BDCA-3+ mDCs. Data represents the mean + SEM of the percent of proliferating T cells
from 3 donors. *= Statistically significant (p≤0.05) difference in the percent of proliferating T cells after coculture with infected and uninfected
cells as calculated by students paired t-test.
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may contribute to their decreased capacity to stimulate T
cell activation. As CD80 is a highly effective ligand for
CTLA-4 on activated T cells [37], upregulation of CD80
on BDCA-1+ and BDCA-3+ mDCs provides a possible
mechanism by which RSV could inhibit T cell prolifera-
tion. CD86 seems to be more important in CD28 interac-
tions, and in Tregs, CD28 activation provides critical
signals needed for proliferation and survival [38,39], thus
providing an additional mechanism for the suppression of
reactive T cell responses. Our findings of significant levels
of CD86 induction by RSV-infected BDCA-3+ mDCs may
then indicate a differential role for BDCA-1+ and BDCA-3+
mDCs in Treg homeostasis during RSV infection. However,
it is likely the relative expression levels of CD80 and CD86
on mDCs dictates the balance between stimulatory
and inhibitory outcomes and work in conjunction to regu-
late T cell proliferation. The differential expression of
PD-L1 by RSV-infected BDCA-1+ and BDCA-3+ mDCs
suggests another mechanism by which RSV infection could
impair the ability of mDCs to stimulate T cell proliferation
as seen in mice [19].
The cytokine milieu present at the time of TCR activa-
tion is crucial in determining the outcome of T cell re-
sponses, and DC-derived cytokines and chemokines areat the center of a complex network of cells that regulate
these signals. We found that RSV-infected BDCA-1+
mDC produced a profile of cytokines and chemokines
associated with pro-inflammatory responses, whereas
BDCA-3+ mDCs did not. Whether the differences in the
cytokine profiles produced by RSV-infected BDCA-1+
and BDCA-3+ mDCs are due to inherent functional dif-
ferences purported to exist between the subsets, or rep-
resents differences in the way RSV interacts with each
mDC subtype is unclear. Activation with poly I:C has
been shown to induce the production of pro-inflamma-
tory cytokines from both BDCA-1+ and BDCA-3+
mDCs, as well as the increased production of IL-12(p70)
by BDCA-3+ mDCs when activated with a cocktail of
poly I:C and additional activation signals [13]. However,
in contrast to purified toll like receptor agonists, viral
pathogens likely activate multiple signaling pathways
that lead to alternative patterns of cytokine expression
by each cell type. Our findings of IL-12(p70) production
by infected BDCA-1+ and not BDCA-3+ mDCs, may
then represent responses specific to infection with RSV.
Findings that as compared to activation with poly I;C,
RSV infected BDCA-1+ mDCs produced greater
amounts of proinflammatory and immunoregulatory
cytokines, whereas RSV-infected BDCA-3+ mDCs
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kines and increased amounts of immunoregulatory cyto-
kines, provides additional evidence for RSV-specific
responses. However, the TLRs governing RSV recogni-
tion, and their subsequent responses, in primary mDC
subsets have yet to be defined. Thus, we cannot exclude
the possibility that the differences in cytokine expression
between RSV and poly I:C treated DCs are related to dif-
ferences in the strength or quality of TLR activation by
RSV, rather than from a virus-specific effect on cell acti-
vation. Further work is needed to determine the cytokine
profiles produced by BDCA-1+ and BDCA-3+ mDCs in
response to infection with other viral pathogens.
The balance of pro-inflammatory cytokines, in particu-
lar IL-12, produced by RSV-infected BDCA-1+ mDCs
suggests that BDCA-1+ mDCs may promote Th1 re-
sponses, whereas RSV-infected BDCA-3+ mDCs, which
produce IL-10 in the setting of low IL-12, may skew
naïve T cells away from Th1 with possible polarization
towards Th2 responses. Although mDCs were not found
to produce IL-4, RSV-infected BDCA-1+ mDCs pro-
duced a number of chemokines implicated in the re-
cruitment of cells known to produce IL-4 [40]. The
potentially divergent roles of RSV-infected BDCA-1+
and BDCA-3+ mDCs in the polarization of T cell
responses may explain why despite findings of Th2
responses in vivo [7,41], in vitro studies have not dem-
onstrated the ability of RSV-infected Mo-DCs to bias
naïve T cells towards Th2 responses [6,17,42]. Of note,
our findings of IL-12 production by BDCA-1+ mDCs
and the lack of significant production of G-CSF, MCP-1
or MIP-1α by BDCA-3+ mDCs are in contrast to a re-
cently published report by Johnson et al. examining the
impact of RSV infection on the maturation and cytokine
response of primary human mDCs isolated using se-
quential immunomagnetic selection alone [25]. These
differences may be related to their use of a recombinant
RSV strain, as well as differences in the methodologies
used to isolate and culture mDC subsets. In prior re-
ports, IL-12 and IFN-γ production by Mo-DCs [18] and
cord-blood derived DCs [30,31] infected with non-
recombinant RSV strains has been demonstrated.
Interestingly, both BDCA-1+ and BDCA-3+ mDCs
produced IL-10 in response to RSV. DC-derived IL-10 is
shown to act in an autocrine fashion to inhibit pro-
inflammatory cytokine production and impair the cap-
acity of DCs to foster Th1 responses [43]. IL-10 pro-
duced by RSV-infected BDCA-1+ and BDCA-3+ mDCs
may then also contribute to the impaired T cell re-
sponses seen in vivo. In prior reports using RSV-infected
Mo-DCs, adding IL-10 blocking antibody did not restore
T cell proliferation or function [17]. However, in vitro
models of E. coli infection demonstrating that infected
BDCA-1+ mDCs, but not Mo-DCs, impair T cellproliferation in an IL-10 dependent manner [44], pro-
vide further evidence that findings in Mo-DCs may not
reflect the function of primary mDCs. IL-10 has also
been used in vitro to generate tolerogenic DCs that are
functionally anergic, and capable of generating and
expanding Tregs [45,46]. In vivo activation of pathways
by pathogens that promote IL-10 production by DCs
could therefore induce functionally tolerogenic DCs
[47]. Tolerogenic DCs are characterized by decreased
production of pro-inflammatory cytokines and increased
production of IL-10 [46]. Similar findings in RSV-
infected BDCA-3+ mDCs suggest that they may be func-
tionally tolerogenic. Although RSV-infected BDCA-1+
mDCs also produced IL-10, the concomitant induction
of IL-12 and other pro-inflammatory cytokines suggests
a non-tolerogenic phenotype, which may explain why
RSV-infected Mo-DCs were not found to generate T
cells with suppressive properties [17]. Studies in murine
models of acute RSV infection [48,49] indicate that
Tregs play an important role in determining the balance
between effective antiviral immunity and controlling
harmful immunopathology in the host response against
RSV. Our findings suggest a possible mechanism for
homeostatic regulation of the Treg compartment by
BDCA-3+ mDCs during RSV infection.
Similar to studies using Mo-DCs and murine DCs
[17-19], RSV infection of BDCA-1+ and BDCA-3+
mDCs impairs their ability to stimulate CD4+ T cell pro-
liferation in a mixed lymphocyte reaction. The lack of
inhibition mDCs exposed to UV-inactivated RSV sug-
gests that viral replication is required to trigger these
events. The mechanism underlying this inhibitory effect
is unknown; however, our findings of differential expres-
sion PD-L1 and IL-10 by RSV-infected mDCs suggest
that RSV modulates the function of BDCA-1+ and
BDCA-3+ mDCs. Although we did consider that the loss
of stimulatory function may be due to reduced viability
of infected cells, there was no difference in cell viability
between uninfected or RSV-infected mDCs.
To our knowledge, this is one of the first studies to
examine the functional responses of highly purified
mDC subsets to infection with RSV. We recognize that
using a reductionist in vitro model does not represent
the interactions between the complex network of mDC
subsets in the lungs and blood during natural infection
and a suitable human model to further study these ques-
tions is needed. Furthermore, although RSV primarily
affects young children, mDC subsets were isolated from
the peripheral blood of healthy adults due to the feasibil-
ity of obtaining sufficient volumes of blood from
pediatric populations. It is not well known whether age
dependent differences in mDC subset function exist
[50]. However, despite these limitations, this study pro-
vides novel evidence for a virus-specific and subset
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sponse of BDCA-1+ and BDCA-3+ mDCs.Conclusions
It is not known what type of mDCs are present in the
lungs during natural RSV infection, or how host genetic
and environmental factors affect the downstream function
of BDCA-1+ and BDCA-3+ mDCs interacting with virus.
However, findings of increased frequencies of BDCA-3+
mDCs in the peripheral blood of atopic asthmatics [51]
suggest that the balance and function of individual mDC
subsets during RSV infection plays a crucial role in deter-
mining the short- and long-term sequela of disease. Defin-
ing the mechanisms by which RSV is able to modulate
virus-specific immune responses will provide important
new insights into the immunopathogenesis of RSV infec-
tion and the role mDC subsets play in the host immune
response against pathogens as a whole.Additional files
Additional file 1: Figure S1. Costimulatory expression by mDC subsets
exposed to UV-inactivated RSV. BDCA-1+ and BDCA-3+ mDCs were
incubated in media alone, or exposed to RSV and UV-inactivated RSV
(non-replicating virus) at a MOI=5 for 40 h. Costimulatory molecule
expression was analyzed using flow cytometry. Dashed line= uninfected
cells, solid line = RSV-infected cells, dotted line= UV-RSV exposed cells.
Additional file 2: Figure S2. Costimulatory molecule expression by
mDCs activated with poly I:C. (A) BDCA-1+ and (B) BDCA-3+ mDCs were
isolated and incubated with poly I:C or media for 40 hours. Data
represent the mean fluorescent intensity (MFI) of costimulatory molecule
expression (mean + SEM of 5 donors) on a linear scale. *=statistically
significant difference (p≤0.05) in expression by poly I:C-activated mDCs as
compared to untreated mDCs by student’s paired t-test.
Additional file 3: Figure S3. Cytokine production by mDCs activated
with poly I:C. (A) BDCA-1+ and (B) BDCA-3+ mDCs were isolated and
incubated with poly I:C or media for 40 hours. Cytokine and chemokine
levels were measured in cell-free supernatant by multiplex assay. Data
represent cytokine production in pg/ml. Box and whisker plots show the
median (central bar), interquartiles (boxes), and range (whiskers) of the
data from 5 donors. Linear data is reported on a logarithmic scale.
*= Statistically significant (p≤0.05) difference in cytokine concentration
between treated and untreated cells as calculated by student’s paired t-test.Abbreviations
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